2.5 tirzepatide units Dosing for Weight Loss in Zepbound Now Has Direct, Cheaper

Effects of GLP-1 receptor agonists on bone mineral density in patients with type 2 diabetes mellitus: a 52-week clinical study

After more studies support a link between tirzepatide drugs like Mounjaro and vision loss, drug companies are using an uncommon tactic

Plot twists are coming!

Programmed Delay-Release MNs: In order to provide a one-month therapeutic agent for type 2 diabetic patients, we incorporated three pixels of delayed burst-release MNs on days 7, 14, and 21 in our system using different composition of PLGA polymer

What Our Happy Patients Are Saying 98% love their experience

Of the 992 participants on an SGLT2i, 65% (647 individuals) were still on therapy for at least 3 years